Cargando…
Grb7 Upregulation Is a Molecular Adaptation to HER2 Signaling Inhibition Due to Removal of Akt-Mediated Gene Repression
The efficacy of anti-HER2 therapeutics, such as lapatinib and trastuzumab, is limited by primary and acquired resistance. Cellular adaptations that allow breast cancer cell to survive prolonged HER2 inhibition include de-repression of the transcription factor FOXO3A with consequent estrogen receptor...
Autores principales: | Nencioni, Alessio, Cea, Michele, Garuti, Anna, Passalacqua, Mario, Raffaghello, Lizzia, Soncini, Debora, Moran, Eva, Zoppoli, Gabriele, Pistoia, Vito, Patrone, Franco, Ballestrero, Alberto |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2814867/ https://www.ncbi.nlm.nih.gov/pubmed/20126311 http://dx.doi.org/10.1371/journal.pone.0009024 |
Ejemplares similares
-
Synergistic Interactions between HDAC and Sirtuin Inhibitors in Human Leukemia Cells
por: Cea, Michele, et al.
Publicado: (2011) -
Catastrophic NAD(+) Depletion in Activated T Lymphocytes through Nampt Inhibition Reduces Demyelination and Disability in EAE
por: Bruzzone, Santina, et al.
Publicado: (2009) -
Cancer associated fibroblasts in hematological malignancies
por: Raffaghello, Lizzia, et al.
Publicado: (2014) -
MYCN: from oncoprotein to tumor-associated antigen
por: Pistoia, Vito, et al.
Publicado: (2012) -
A Novel Mechanism of Soluble HLA-G Mediated Immune Modulation: Downregulation of T Cell Chemokine Receptor Expression and Impairment of Chemotaxis
por: Morandi, Fabio, et al.
Publicado: (2010)